About Pyramid Bio
Pyramid Bio is a company based in Waltham (United States) founded in 2015.. Pyramid Bio has raised $71.19 million across 5 funding rounds from investors including AUM 13F, Adage Capital Management and Prospect Hill Growth Partners. The company has 3 employees as of December 31, 2020. Pyramid Bio operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Waltham, United States
- Employees 3 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pyramid Biosciences, Inc.,
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$71.19 M (USD)
in 5 rounds
-
Latest Funding Round
$33.54 M (USD), Series C
Oct 15, 2021
-
Investors
AUM 13F
& 2 more
-
Employee Count
3
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Pyramid Bio
Pyramid Bio has successfully raised a total of $71.19M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $33.54 million completed in October 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series C — $33.5M
-
First Round
First Round
(01 Nov 2016)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2021 | Amount | Series C - Pyramid Bio | Valuation |
investors |
|
| Aug, 2020 | Amount | Series B - Pyramid Bio | Valuation | Adage Capital Management , AUM 13F |
|
| Jul, 2020 | Amount | Series B - Pyramid Bio | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Pyramid Bio
Pyramid Bio has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include AUM 13F, Adage Capital Management and Prospect Hill Growth Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Limited information is provided about the company's activities.
|
Founded Year | Domain | Location | |
|
Offers investment management and secure information access to clients and partners.
|
Founded Year | Domain | Location | |
|
Due diligence tools for asset managers
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Pyramid Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Pyramid Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pyramid Bio Comparisons
Competitors of Pyramid Bio
Pyramid Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pyramid Bio
Frequently Asked Questions about Pyramid Bio
When was Pyramid Bio founded?
Pyramid Bio was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Pyramid Bio located?
Pyramid Bio is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Is Pyramid Bio a funded company?
Pyramid Bio is a funded company, having raised a total of $71.19M across 5 funding rounds to date. The company's 1st funding round was a Series B of $6M, raised on Nov 01, 2016.
How many employees does Pyramid Bio have?
As of Dec 31, 2020, the latest employee count at Pyramid Bio is 3.
What does Pyramid Bio do?
Pyramid Bio was founded in 2015 and is based in Waltham, United States. Small molecules are developed by the company for dermatology and oncology disorders. The lead candidate, PBI-100, functions as a selective TRK modulator with anti-inflammatory and antiproliferative effects and is advanced for psoriasis and atopic dermatitis in phase 1 trials. Another candidate, PBI-200, serves as a TRK inhibitor for solid and liquid tumors.
Who are the top competitors of Pyramid Bio?
Pyramid Bio's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Who are Pyramid Bio's investors?
Pyramid Bio has 3 investors. Key investors include AUM 13F, Adage Capital Management, and Prospect Hill Growth Partners.